Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
drug
|
| gptkbp:administrativeDivision |
once daily
|
| gptkbp:analyzes |
submitted
multiple principal investigators |
| gptkbp:clinicalTrials |
gptkb:Asterias_Biotherapeutics
ongoing various hospitals NCT04512345 expected in 2024 pending publication |
| gptkbp:collaborations |
various research institutions
|
| gptkbp:collection |
prospective
|
| gptkbp:community_service |
safety and efficacy
|
| gptkbp:contraindication |
monitored
|
| gptkbp:courseRating |
randomized controlled trial
|
| gptkbp:customerFeedback |
collected during trial
|
| gptkbp:dataUsage |
established
|
| gptkbp:developedBy |
gptkb:Asterias_Biotherapeutics
|
| gptkbp:dosageForm |
to be defined
|
| gptkbp:evaluates |
preliminary results available
|
| gptkbp:formulation |
injectable solution
|
| gptkbp:future_plans |
Phase 2
|
| gptkbp:healthcare |
ongoing
specific criteria required during trial |
| gptkbp:historicalResearch |
synthetic
with pharmaceutical companies planned for next phases |
| https://www.w3.org/2000/01/rdf-schema#label |
ASTX220
|
| gptkbp:impact |
to be determined
|
| gptkbp:mandates |
respiratory viral infections
|
| gptkbp:market |
not available
|
| gptkbp:patentStatus |
patented
|
| gptkbp:productionCompany |
early clinical development
|
| gptkbp:regulatoryCompliance |
not approved yet
|
| gptkbp:research |
public and private sources
government grants |
| gptkbp:research_areas |
antiviral
|
| gptkbp:researchAndDevelopment |
awaiting results
|
| gptkbp:researchFocus |
viral infections
|
| gptkbp:researchInterest |
academic institutions
clinical evaluation in peer-reviewed journals obtained to be assessed evaluate treatment effects improve treatment protocols potential to improve outcomes to be analyzed |
| gptkbp:route |
intravenous
|
| gptkbp:safetyFeatures |
under investigation
|
| gptkbp:sideEffect |
to be determined
|
| gptkbp:sponsor |
gptkb:Asterias_Biotherapeutics
|
| gptkbp:status |
clinical trial
|
| gptkbp:targets |
gptkb:COVID-19
hospitalized patients |
| gptkbp:triggerType |
immune modulation
|
| gptkbp:type |
therapeutic agent
|